NASDAQ
Benitec Biopharma Inc. (BNTC) has a free cash flow growth of -30.13% as of Friday, May 29, 2026. This represents a 76.64% decrease compared to its 12-month average of -17.06%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.